Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hammann

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Tobacco Induced Diseases|July 25, 2025
Knowledge and perceptions of nicotine, smoking cessation and electronic nicotine delivery systems among physicians and pharmacists in a Swiss hospital groupSamuel E Christen, Elisabetta Scanniello, Felix Hammann, et al.
Digestion|December 5, 2008
Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controlsHeike Gutmann, Petr Hruz, Christian Zimmermann, et al.
Clinical Pharmacokinetics|February 16, 2017
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy SubjectsPatrick C Dolder, Yasmin Schmid, Andrea E Steuer, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infectionLaura Hermann, Verena Schöning, Sarah Dräger, et al.
Frontiers in Pharmacology|June 5, 2026
Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligenceVerena Schöning, Gaia Alluisetti, Katharina Elisabeth Grafinger, et al.
Scientific Reports|October 14, 2020
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in ratsCarlos Chaccour, Gloria Abizanda, Ángel Irigoyen-Barrio, et al.
Malaria Journal|April 16, 2015
Screening for an ivermectin slow-release formulation suitable for malaria vector controlCarlos Chaccour, Ángel Barrio, Ana Gloria Gil Royo, et al.
Journal of Analytical Toxicology|January 29, 2017
Mistaking 2C-P for 2C-B: What a Difference a Letter MakesAdrian Stoller, Patrick C Dolder, Michael Bodmer, et al.
BMJ Open|December 31, 2025
Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a randomised, double-blind, placebo-controlled, non-inferiority, multicentre study in SwitzerlandChristina Kotoula, Maria M Wertli, Konrad Streitberger, et al.
Frontiers in Medicine|June 3, 2022
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the LiteratureVanessa Alexandra Buetler, Nada Agbariah, Deborah Pia Schild, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Tobacco Induced Diseases|July 25, 2025
Knowledge and perceptions of nicotine, smoking cessation and electronic nicotine delivery systems among physicians and pharmacists in a Swiss hospital groupSamuel E Christen, Elisabetta Scanniello, Felix Hammann, et al.
Digestion|December 5, 2008
Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controlsHeike Gutmann, Petr Hruz, Christian Zimmermann, et al.
Clinical Pharmacokinetics|February 16, 2017
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy SubjectsPatrick C Dolder, Yasmin Schmid, Andrea E Steuer, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infectionLaura Hermann, Verena Schöning, Sarah Dräger, et al.
Frontiers in Pharmacology|June 5, 2026
Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligenceVerena Schöning, Gaia Alluisetti, Katharina Elisabeth Grafinger, et al.
Scientific Reports|October 14, 2020
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in ratsCarlos Chaccour, Gloria Abizanda, Ángel Irigoyen-Barrio, et al.
Malaria Journal|April 16, 2015
Screening for an ivermectin slow-release formulation suitable for malaria vector controlCarlos Chaccour, Ángel Barrio, Ana Gloria Gil Royo, et al.
Journal of Analytical Toxicology|January 29, 2017
Mistaking 2C-P for 2C-B: What a Difference a Letter MakesAdrian Stoller, Patrick C Dolder, Michael Bodmer, et al.
BMJ Open|December 31, 2025
Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a randomised, double-blind, placebo-controlled, non-inferiority, multicentre study in SwitzerlandChristina Kotoula, Maria M Wertli, Konrad Streitberger, et al.
Frontiers in Medicine|June 3, 2022
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the LiteratureVanessa Alexandra Buetler, Nada Agbariah, Deborah Pia Schild, et al.
Pageof 7